FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gerda Saletu-Zyhlarz

Research Profile

Procedures

Disorders

Physiology

Concepts & Ideas

Anatomy

Brain

Chemicals & Drugs

Devices

Placebos

Co-author Network

Publications

TOP 3
Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease.
Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
Comparative EEG mapping studies in Huntington's disease patients and controls.
Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz
EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gerda Saletu-Zyhlarz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease.
Journal of neurology 2011;258(5):840-54.
2010: Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
Comparative EEG mapping studies in Huntington's disease patients and controls.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(11):1307-18.
2010: Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz
EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2010;41(4):203-10.
2010: Michael Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Silvia Parapatics; Georg Gruber; Saba Nia; Bernd Saletu
Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(4):463-73.
2010: Peter Anderer; Arnaud Moreau; Michael Woertz; Marco Ross; Georg Gruber; Silvia Parapatics; Erna Loretz; Esther Heller; Andrea Schmidt; Marion Boeck; Doris Moser; Gerhard Kloesch; Bernd Saletu; Gerda Saletu-Zyhlarz; Heidi Danker-Hopfe; Josef Zeitlhofer; Georg Dorffner
Computer-assisted sleep classification according to the standard of the American Academy of Sleep Medicine: validation study of the AASM version of the Somnolyzer 24 × 7.
Neuropsychobiology 2010;62(4):250-64.
2009: Michael Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Magdalena Mandl; Bernd Saletu; Josef Zeitlhofer
Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
Sleep medicine 2009;10(8):850-8.
2009: Bernd Saletu; Peter Anderer; Michael Wolzt; Dorothea Nosiska; Alessandro Assandri; Emanuele Noseda; Fabrizio Nannipieri; Gerda Saletu-Zyhlarz
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
Neuropsychobiology 2009;59(2):110-22.
2009: Gerda Saletu-Zyhlarz; Peter Anderer; Michael Wolzt; Heribert V Semlitsch; Alessandro Assandri; Paola Nessi; Fabrizio Nannipieri; Sergio Rosini; Bernd Saletu
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
Neuropsychobiology 2009;59(2):100-9.
2008: Michael Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Magdalena Mandl; Josef Zeitlhofer; Bernd Saletu
Event-related-potential low-resolution brain electromagnetic tomography (ERP-LORETA) suggests decreased energetic resources for cognitive processing in narcolepsy.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2008;119(8):1782-94.
2008: Peter Anderer; Bernd Saletu; Michael Wolzt; Svetlana Culic; Alessandro Assandri; Fabrizio Nannipieri; Sergio Rosini; Gerda Saletu-Zyhlarz
Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
Human psychopharmacology 2008;23(3):243-54.
2007: Claudia Trenkwalder; Heike Benes; Ludger Grote; Svenja Happe; Birgit Högl; Johannes Mathis; Gerda Saletu-Zyhlarz; Ralf Kohnen
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.
Movement disorders : official journal of the Movement Disorder Society 2007;22(5):696-703.
2007: Michael Saletu; Peter Anderer; Heribert V Semlitsch; Gerda Saletu-Zyhlarz; Magdalena Mandl; Josef Zeitlhofer; Bernd Saletu
Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
Psychiatry research 2007;154(1):69-84.
2006: Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz
EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2006;37(2):66-80.
2005: Oliver Arnold; Bernd Saletu; Peter Anderer; Alessandro Assandri; Carlo Di Padova; Mario E Corrado; Gerda Saletu-Zyhlarz
Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):533-43.
2005: Ines Hertling; Katrin Ramskogler; Alexander Dvorak; Anton Klingler; Gerda Saletu-Zyhlarz; Rudolf Schoberberger; Henriette Walter; Michael Kunze; Otto M Lesch
Craving and other characteristics of the comorbidity of alcohol and nicotine dependence.
European psychiatry : the journal of the Association of European Psychiatrists 2005;20(5-6):442-50.
2005: Peter Anderer; Bernd Saletu; Diego Gruber; Leopold Linzmayer; Heribert V Semlitsch; Gerda Saletu-Zyhlarz; Nadja Brandstätter; Markus Metka; Johannes Huber
Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials.
Maturitas 2005;51(3):254-69.
2005: Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Roberto D Pascual-Marqui
EEG mapping and low-resolution brain electromagnetic tomography (LORETA) in diagnosis and therapy of psychiatric disorders: evidence for a key-lock principle.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2005;36(2):108-15.
2005: Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Diego Gruber; Markus Metka; Johannes Huber
Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).
Psychopharmacology 2005;178(4):389-99.
2005: Michael Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Magdalena Mandl; Oliver Arnold; Dorothea Nosiska; Josef Zeitlhofer; Bernd Saletu
EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
European archives of psychiatry and clinical neuroscience 2005;255(1):20-32.
2005: Alexander Saletu; Silvia Parapatics; Bernd Saletu; Peter Anderer; Wolfgang Prause; Hanna Putz; Josef Adelbauer; Gerda Saletu-Zyhlarz
On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam.
Neuropsychobiology 2005;51(4):214-25.
2005: Bernd Saletu; Wolfgang Prause; Peter Anderer; Magdalena Mandl; Martin Aigner; Olya Mikova; Gerda Saletu-Zyhlarz
Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Neuropsychobiology 2005;51(3):148-63.
2004: Michael Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Magdalena Mandl; Oliver Arnold; Josef Zeitlhofer; Bernd Saletu
EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
Journal of neurology 2004;251(11):1354-63.
2004: Gerda Saletu-Zyhlarz; Oliver Arnold; Peter Anderer; Stefan Oberndorfer; Henriette Walter; Otto M Lesch; Jobst Böning; Bernd Saletu
Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mapping.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(3):233-40.
2004: Otto M Lesch; Alexander Dvorak; Ines Hertling; Anton Klingler; Michael Kunze; Katrin Ramskogler; Gerda Saletu-Zyhlarz; Rudolf Schoberberger; Henriette Walter
The Austrian multicentre study on smoking: subgroups of nicotine dependence and their craving.
Neuropsychobiology 2004;50(1):78-88.
2004: Peter Anderer; Bernd Saletu; Gerda Saletu-Zyhlarz; Diego Gruber; Markus Metka; Johannes Huber; Roberto D Pascual-Marqui
Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
Neuropsychobiology 2004;49(3):134-53.
2003: Gerda Saletu-Zyhlarz; Peter Anderer; Georg Gruber; Magdalena Mandl; Diego Gruber; Markus Metka; Johannes Huber; Michael Oettel; Thomas Gräser; Manal Hassan Abu-Bakr; Elisabeth Grätzhofer; Bernd Saletu
Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
Journal of sleep research 2003;12(3):239-54.
2003: Michael Saletu; Peter Anderer; Birgit Högl; Gerda Saletu-Zyhlarz; A Kunz; Werner Poewe; Bernd Saletu
Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(6):611-26.
2003: Wolfgang Prause; Bernd Saletu; Peter Anderer; Georg Gruber; Henriette Löffler-Stastka; Gerhard Klösch; Magdalena Mandl; Elisabeth Grätzhofer; Gerda Saletu-Zyhlarz; Heinz Katschnig
Quality of life in nonorganic and organic sleep disorders: II. Correlation with objective and subjective quality of sleep and awakening.
Wiener klinische Wochenschrift 2003;115(10):326-33.
2003: Bernd Saletu; Wolfgang Prause; Henriette Löffler-Stastka; Peter Anderer; Nadja Brandstätter; Ali Zoghlami; Gerda Saletu-Zyhlarz; Heinz Katschnig
Quality of life in nonorganic and organic sleep disorders: I. Comparison with normative data.
Wiener klinische Wochenschrift 2003;115(7-8):246-54.
2003: Peter Anderer; Heribert V Semlitsch; Bernd Saletu; Gerda Saletu-Zyhlarz; Diego Gruber; Markus Metka; Johannes Huber; Thomas Gräser; Michael Oettel
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
Psychoneuroendocrinology 2003;28(3):419-45.
2003: Gerda Saletu-Zyhlarz; Peter Anderer; Oliver Arnold; Bernd Saletu
Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Neuropsychobiology 2003;48(4):194-208.
2003: Ines Hertling; Michael Philipp; Alexander Dvorak; Thomas Glaser; O Mast; Manfred Beneke; Katrin Ramskogler; Gerda Saletu-Zyhlarz; Henriette Walter; Otto M Lesch
Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients.
Neuropsychobiology 2003;47(1):37-46.
2002: Bernd Saletu; Peter Anderer; Leopold Linzmayer; Heribert V Semlitsch; Elisabeth Lindeck-Pozza; Alessandro Assandri; Carlo Di Padova; Gerda Saletu-Zyhlarz
Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(12):1505-26.
2002: Bernd Saletu; Peter Anderer; Diego Gruber; Markus Metka; Johannes Huber; Gerda Saletu-Zyhlarz
Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
Maturitas 2002;43(3):165-81.
2002: Bernd Saletu; Peter Anderer; Michael Saletu; Catharina Hauer; L Lindeck-Pozza; Gerda Saletu-Zyhlarz
EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls.
Sleep medicine 2002;3 Suppl():S35-42.
2002: Bernd Saletu; Peter Anderer; Carlo Di Padova; Alessandro Assandri; Gerda Saletu-Zyhlarz
Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography.
The American journal of clinical nutrition 2002;76(5):1162S-71S.
2002: Gerda Saletu-Zyhlarz; Peter Anderer; Leopold Linzmayer; Heribert V Semlitsch; Alessandro Assandri; Wolfgang Prause; Manal Hassan Abu-Bakr; Elisabeth Lindeck-Pozza; Bernd Saletu
Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2002;5(3):199-215.
2002: Michael Saletu; Peter Anderer; Bernd Saletu; Lisa Lindeck-Pozza; Catharina Hauer; Gerda Saletu-Zyhlarz
EEG mapping in patients with restless legs syndrome as compared with normal controls.
Psychiatry research 2002;115(1-2):49-61.
2002: Michael Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Catharina Hauer; Bernd Saletu
Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
European archives of psychiatry and clinical neuroscience 2002;252(4):185-94.
2002: Gerda Saletu-Zyhlarz; Manal Hassan Abu-Bakr; Peter Anderer; Georg Gruber; Magdalena Mandl; Roland Strobl; Dietmar Gollner; Wolfgang Prause; Bernd Saletu
Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(2):249-60.
2002: Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Oliver Arnold; Roberto D Pascual-Marqui
Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA).
Methods and findings in experimental and clinical pharmacology 2002;24 Suppl C():97-120.
2002: Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Roberto D Pascual-Marqui
EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle.
Methods and findings in experimental and clinical pharmacology 2002;24 Suppl D():97-106.
2002: Gerda Saletu-Zyhlarz; Oliver Arnold; Bernd Saletu; Peter Anderer
The key-lock principle in the diagnosis and treatment of nonorganic insomnia related to psychiatric disorders: sleep laboratory investigations.
Methods and findings in experimental and clinical pharmacology 2002;24 Suppl D():37-49.
2001: Bernd Saletu; Peter Anderer; Gerda Saletu-Zyhlarz
[Nonorganic hypersomnia: epidemiology, diagnosis, and therapy].
Wiener klinische Wochenschrift 2001;113(7-8):266-77.
2001: Michael Saletu; Peter Anderer; Gerda Saletu-Zyhlarz; Wolfgang Prause; B Semler; Ali Zoghlami; Georg Gruber; Catharina Hauer; Bernd Saletu
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(2):153-61.
2001: Gerda Saletu-Zyhlarz; Manal Hassan Abu-Bakr; Peter Anderer; B Semler; Kathrin Decker; Silvia Parapatics; U Tschida; A Winkler; Bernd Saletu
Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone.
Neuropsychobiology 2001;44(3):139-49.
2001: Leopold Linzmayer; Heribert V Semlitsch; Bernd Saletu; G Böck; Gerda Saletu-Zyhlarz; Ali Zoghlami; Diego Gruber; Markus Metka; Johannes Huber; Michael Oettel; Thomas Gräser; Josef Grünberger
Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
Arzneimittel-Forschung 2001;51(3):238-45.
2000: Stefan Oberndorfer; Bernd Saletu; Georg Gruber; Peter Anderer; Michael Saletu; Magdalena Mandl; Gerda Saletu-Zyhlarz
Theophylline in snoring and sleep-related breathing disorders: sleep laboratory investigations on subjective and objective sleep and awakening quality.
Methods and findings in experimental and clinical pharmacology 2000;22(4):237-45.
2000: Michael Saletu; Catharina Hauer; Peter Anderer; Gerda Saletu-Zyhlarz; Georg Gruber; Stefan Oberndorfer; Magdalena Mandl; R Popovic; Bernd Saletu
[Daytime tiredness correlated with nocturnal respiratory and arousal variables in patients with sleep apnea: polysomnographic and EEG mapping studies].
Wiener klinische Wochenschrift 2000;112(6):281-9.
2000: Stefan Oberndorfer; Gerda Saletu-Zyhlarz; Bernd Saletu
Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality.
Neuropsychobiology 2000;42(2):69-81.
2000: Michael Saletu; Peter Anderer; Bernd Saletu; Catharina Hauer; Magdalena Mandl; Stefan Oberndorfer; Ali Zoghlami; Gerda Saletu-Zyhlarz
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables.
Neuropsychobiology 2000;41(4):190-9.
2000: Bernd Saletu; Georg Gruber; Michael Saletu; Nadja Brandstätter; Catharina Hauer; Wolfgang Prause; K Ritter; Gerda Saletu-Zyhlarz
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.
Neuropsychobiology 2000;41(4):181-9.
2000: Gerda Saletu-Zyhlarz; Peter Anderer; Nadja Brandstätter; Karl Dantendorfer; Georg Gruber; Magdalena Mandl; K Ritter; Ali Zoghlami; Bernd Saletu
Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Neuropsychobiology 2000;41(3):139-48.
1999: Josef Grünberger; Leopold Linzmayer; Henriette Walter; Michael K Rainer; Andreas J Masching; Lukas Pezawas; Gerda Saletu-Zyhlarz; Hans Stöhr; M Grünberger
Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
Neuropsychobiology 1999;40(1):40-6.
1999: Bernd Saletu; Stefan Oberndorfer; Peter Anderer; Georg Gruber; H Divos; A Lachner; Magdalena Mandl; Silvia Parapatics; W Popp; Michael Saletu; Gerda Saletu-Zyhlarz; K Sertl; R Strobl; U Tschida; A Winkler
Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: comparative sleep laboratory studies on objective and subjective sleep and awakening quality.
Neuropsychobiology 1999;39(3):151-9.
1998: Josef Grünberger; Leopold Linzmayer; Henriette Walter; Hans Stöhr; Gerda Saletu-Zyhlarz; M Grünberger; Otto M Lesch
Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiency.
Alcohol and alcoholism (Oxford, Oxfordshire) 1998;33(5):541-8.
1997: Josef Grünberger; Bernd Saletu; Leopold Linzmayer; G Böck; S Weissgram; N Brandstaätter; Richard Frey; Gerda Saletu-Zyhlarz
Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
Methods and findings in experimental and clinical pharmacology 1997;19(9):645-54.
1997: Bernd Saletu; Nadja Brandstätter; Richard Frey; Gerda Saletu-Zyhlarz; Karl Dantendorfer; Peter Berger; H Löffler
[Clinical aspects of sleep disorders--experiences with 817 patients of an ambulatory sleep clinic; comment].
Wiener klinische Wochenschrift 1997;109(11):390-9.
1997: Bernd Saletu; Gerda Saletu-Zyhlarz; Peter Anderer; Nadja Brandstätter; Richard Frey; Georg Gruber; Gerhard Klösch; Magdalena Mandl; Josef Grünberger; Leopold Linzmayer
Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Neuropsychobiology 1997;36(3):130-52.
1997: Gerda Saletu-Zyhlarz; Bernd Saletu; Peter Anderer; Nadja Brandstätter; Richard Frey; Georg Gruber; Gerhard Klösch; Magdalena Mandl; Josef Grünberger; Leopold Linzmayer
Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping.
Neuropsychobiology 1997;36(3):117-29.